<prompt> Answer this question truthfullyWhat type of cancer, characterized by VEGFR overexpression, can be treated with Sunitinib and Sorafenib?  <response>: <reason> Sunitinib and Sorafenib can treat cancer characterized by VEGFR overexpression, such as renal cell carcinoma. 